# Adalimumab-bwwd

NDC: 83457-187
Generic name: adalimumab-bwwd
Labeler / Manufacturer: Cordavis Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20251212

FDA application: BLA761059

## Active ingredients

- ADALIMUMAB: 40 mg/.4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83457-187"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83457-187
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c24655e5-796e-4127-b716-92f08d649c83